Immunogenicity 12073
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SLC25A22
Transcript ID
uc009yci.3
HLA INFO
C*02:02
TCR INFO
No TCR info found!
Full length protein sequence (323 aa)
MADKQ
1
ISLPA
6
KLING
11
GIAGL
16
IGVTC
21
VFPID
26
LAKTR
31
LQNQQ
36
NGQRV
41
YTSMS
46
DCLIK
51
TVRSE
56
GYFGM
61
YRGAA
66
VNLTL
71
VTPEK
76
AIKLA
81
ANDFF
86
RHQLS
91
KDGQK
96
LTLLK
101
EMLAG
106
CGAGT
111
CQVIV
116
TTPME
121
MLKIQ
126
LQDAG
131
RIAAQ
136
RKILA
141
AQGQL
146
SAQGG
151
AQPSV
156
EAPAA
161
PRPTA
166
TQLTR
171
DLLRS
176
RGIAG
181
LYKGL
186
GATLL
191
RDVPF
196
SVVYF
201
PLFAN
206
LNQLG
211
RPASE
216
EKSPF
221
YVSFL
226
AGCVA
231
GSAAA
236
VAVNP
241
CDVVK
246
TRLQS
251
LQRGV
256
NEDTY
261
SGILD
266
CARKI
271
LRHEG
276
PSAFL
281
KGAYC
286
RALVI
291
APLFG
296
IAQVV
301
YFLGI
306
AESLL
311
GLLQD
316
PQA
321
Mutation Information
DNA mutation:
None
Peptide Range:
269 ~ 293
Mut AA position:
281 (13 in Wild Type peptide)
Alignment
Wild Type:
"LDCARKILRHEGPSAFLKGAYCRAL
||||||||||||.||||||||||||
Mutant:
LDCARKILRHEGSSAFLKGAYCRAL"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) SLC25A22
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay